EMBRACE: Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers
Lead SiteCambridge
Local Principal InvestigatorProfessor Gareth Evans
Study Statusrecruiting
Main AimsThe aims of this study are two-fold:
UK Coordinating Centre – Cambridge. The Royal Marsden Hospital (Surrey), St Bartholomew’s Hospital Bristol, Belfast City Hospital, Belfast, Ysbyty Glan Clwyd, Birmingham Women’s Hospital, Addenbrooke’s Hospital Cambridge, University Hospital Of Wales, St Mary’s Hospital Manchester, Great Ormond Street Hospital Central London, Guy’s Hospital London, St James’s University Hospital, Northwick Park Hospital Harrow, Aberdeen Royal Infirmary Aberdeen, Western General Hospital Edinburgh, Nottingham University Hospitals Nhs Trust – City Campus, Churchill Hospital Oxford, Royal Devon & Exeter Hospital (Wonford), Southend Hospital Southend-On-Sea, St George’s Hospital (Tooting), The Newcastle Upon Tyne Hospitals Nhs Foundation Trust, Princess Anne Hospital, Leicester Royal Infirmary, Singleton Hospital Cwmrhydyceirw, Chapel Allerton Hospital Leeds, Liverpool Womens Hospital, Royal Hospital For Sick Children (Glasgow), Southern General Hospital Glasgow, Raigmore Hospital Inverness, Sheffield Children’s Hospital, St Michael’s Hospital Bristol
For more information click here